Executives from the Marlborough, MA-based company discussed its position in the fast-growing pulsed-field ablation market.

Boston Scientific expects incredibly high growth for its pulsed field ablation (PFA) devices, driven by increased usage of its existing catheters.

The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain ...

Medtronic asserted that key markets it targets including PFA and renal denervation represent lucrative opportunities in the ...

Boston Scientific has enjoyed success in the cardiac device space, but it continues to look to gain market share elsewhere, ...

Field Medical Inc., a clinical-stage medical technology company advancing a versatile, next-generation pulsed field ablation ...

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond ...

Field Medical Inc., a clinical-stage medical technology company advancing a versatile, next-generation pulsed field ablation ...

Going after players in January is always a risky strategy with prices often inflated, but several clubs have struck gold ...

UNIONDALE, NY / ACCESS Newswire / December 18, 2025 / Marquis Who’s Who, the trusted biographical authority documenting ...

Upbound Group, Inc. ("Upbound" or the "Company") , a technology and data-driven leader in accessible and inclusive financial solutions that address the evolving needs and aspirations of underserved ...

Ionis Pharmaceuticals, Inc. today announced that Brett P. Monia, Ph.D., chief executive officer, will present a company overview at the 44th Annual J.P. Morgan Healthcare Conference at 8:15 a.m. PT on ...